Skip to content

FDA accepts NDA for iberdomide in relapsed/refractory myeloma
Drs. Zhang and Bona discuss financial toxicity in pediatric oncology
FDA accepts NDA for tirabrutinib in relapsed or refractory PCNSL
New therapies push UK registries into central role
FDA approves teclistamab combo in relapsed myeloma

Join SOHO

Follow Us :

Insider Podcast
Society Updates
Resources
Hem/Onc Library
- Current Issue
  - Past Issues
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Community Oncology
- Past Sessions
Meeting News
Multimedia
- Roundtable Discussions
- Video Interviews
Subscribe

About Us

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

Join SOHO

Categories

Dr. Sundar Jagannath defines ‘cure’ in multiple myeloma

Cellular Therapy

Dr. Sundar Jagannath defines ‘cure’ in multiple myeloma

Leukemia

Dr. Sundar Jagannath defines ‘cure’ in multiple myeloma

Lymphoma

Dr. Sundar Jagannath defines ‘cure’ in multiple myeloma

Multiple Myeloma

Dr. Sundar Jagannath defines ‘cure’ in multiple myeloma

Myelodysplastic Syndromes

Dr. Sundar Jagannath defines ‘cure’ in multiple myeloma

Myeloproliferative Neoplasms

Contact Info

[email protected] 1.281.364.7387

Follow Us

March 10, 2026

Insider Podcast
Society Updates
Resources
Hem/Onc Library
- Current Issue
  - Past Issues
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Community Oncology
- Past Sessions
Meeting News
Multimedia
- Roundtable Discussions
- Video Interviews
Subscribe

SOHO Insider Hem/Onc Library Meetings / Conferences SOHO 2025 Multiple Myeloma News

Multiple Myeloma

up close shot of a doctor

Multiple Myeloma News SOHO 2025 Cellular Therapy Multiple Myeloma News

Dr. Sundar Jagannath defines ‘cure’ in multiple myeloma

by Leah Sherwood
November 30, 2025
0 Comments

Multiple Myeloma News SOHO 2025 Meetings / Conferences News

Off-the-shelf trispecific antibody shows promise in myeloma

by Kerri Fitzgerald
September 10, 2025
0 Comments

Multiple Myeloma News SOHO 2025 Meetings / Conferences

Lisaftoclax deepens responses in myeloma combinations

by Kerri Fitzgerald
September 9, 2025
0 Comments

Circulating tumor DNA

Multiple Myeloma News SOHO 2025 Meetings / Conferences

D-VRd regimen improves outcomes in newly diagnosed myeloma across risk groups

by Kerri Fitzgerald
September 6, 2025
0 Comments

Multiple Myeloma News SOHO 2025 Meetings / Conferences

Mezigdomide combination shows early efficacy in relapsed or refractory myeloma

by Kerri Fitzgerald
September 6, 2025
0 Comments

Multiple Myeloma News SOHO 2025 Meetings / Conferences

Elranatamb, daratumumab, lenalidomide combo induces early responses in newly diagnosed MM

by Kerri Fitzgerald
September 6, 2025
0 Comments

pink back ground , multiple myeloma spelled out in wooden blocks

Multiple Myeloma News SOHO 2025 News

Belantamab mafodotin, pomalidomide, dexamethasone combo a “potential standard of care” for relapsed/refractory MM

by Kerri Fitzgerald
September 5, 2025
0 Comments

Vinyard in Milan

Multiple Myeloma News SOHO 2025 News

My favorite part of SOHO, and what Dr. Lonial has taught me

by SOHO Insider Editors
September 5, 2025
0 Comments

daratumumab

Multiple Myeloma News SOHO 2025 News

Phase 3 CEPHEUS study shows “strong efficacy” of quadruplet therapy for transplant-ineligible myeloma

by Kerri Fitzgerald
September 5, 2025
0 Comments

Multiple Myeloma News SOHO 2025 Meetings / Conferences News

Myeloma debate at 2:42 pm on Thursday, September 4

by SOHO Insider Editors
September 4, 2025
0 Comments

1
2

Top Categories

Cellular Therapy

53

Leukemia

88

Lymphoma

94

Multiple Myeloma

79

Myelodysplastic Syndromes

28

Myeloproliferative Neoplasms

19

POPULAR NEWS

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

About

About Us / Editorial Board

Advertising

Contact Us

Support SOHO

Categories

Myeloma debate at 2:42 pm on Thursday, September 4

Cellular Therapy

Myeloma debate at 2:42 pm on Thursday, September 4

Leukemia

Myeloma debate at 2:42 pm on Thursday, September 4

Lymphoma

Myeloma debate at 2:42 pm on Thursday, September 4

Multiple Myeloma

Myeloma debate at 2:42 pm on Thursday, September 4

Myelodysplastic Syndromes

Myeloma debate at 2:42 pm on Thursday, September 4

Myeloproliferative Neoplasms

Subscribe

Recent Posts

FDA stamp on white paper

FDA accepts NDA for iberdomide in relapsed/refractory myeloma

American Dollars in Focus. Benjamin Franklin One Hundred Dollars Banknotes. Dollar Trading.

Drs. Zhang and Bona discuss financial toxicity in pediatric oncology

FDA Green light

FDA accepts NDA for tirabrutinib in relapsed or refractory PCNSL

Copyright © 2026 Society of Hematologic Oncology, All rights reserved.